HPLC analysis and pharmacokinetics of icariin in rats

被引:30
作者
Cheng, Shan
Qiu, Feng
Wang, Shuhui
He, Junqi
机构
[1] Capital Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100069, Peoples R China
[2] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China
[3] Capital Med Univ, Beijing Friendship Hosp, Dept Neurol, Beijing, Peoples R China
关键词
HPLC; icariin; pharmacokinetics; rat;
D O I
10.1002/jssc.200600313
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
As a prerequisite to the determination of pharmacokinetic parameters of icariin in rats, an HPLC method using UV detection was developed and validated. Icariin and the internal standard, quercetin, were extracted from plasma samples using ethyl acetate after acidification with 0.05 mol/L NaH2PO4 solution (pH 5.0). Chromatogra- phic separation was achieved on an Agilent XDB C-18 column (250 x 4.6 mm id, 5 mu m) equipped with a Shim-pack GVP-ODS C-18 guard column (10 x 4.6 mm id, 5 mu m) using a mobile phase of ACN/water/acetic acid (31:69:0.4 v/v/v) at a flow rate of 1.0 mL/ min. Detection was at 277 nm. The calibration curve was linear from 0.05 to 100.0 mu g/mL with 0.05 mu g/mL as the lower LOQ (LLOQ) in plasma. The intra- and interday precisions in terms of RSD were lower than 5.7 and 7.8% in rat plasma, respectively. The accuracy in terms of relative error (RE) ranged from - 1.6 to 3.2%. The extraction recoveries of icariin and quercetin were 87.6 and 80.1%, respectively. The main pharmacokinetic parameters for rats were determined after a single intravenous administration of 10 mg/kg icariin: t(1/2), 0.562 +/- 0.200 h; AUC(0-infinity), 8.73 +/- 2.23 mu g center dot h/mL; CLTOT, 20.10 +/- 5.80 L/kg center dot h; V-z, 1.037 +/- 0.631 L/kg; MRT0-infinity, 0.134 +/- 0.040 h; and V-ss, 0.170 +/- 0.097 L/kg.
引用
收藏
页码:1307 / 1312
页数:6
相关论文
共 14 条
  • [1] Chen KM, 2005, PHARMAZIE, V60, P939
  • [2] HE W, 1995, ARZNEIMITTELFORSCH, V45-2, P910
  • [3] Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production
    Jia, TL
    Wang, HZ
    Xie, LP
    Wang, XY
    Zhang, RQ
    [J]. BIOCHEMICAL PHARMACOLOGY, 2003, 65 (05) : 709 - 715
  • [4] LIANG HR, 1988, ACTA PHARM SINICA, V23, P34
  • [5] Determination of icariin and metabolites in rat serum by capillary zone electrophoresis: rat pharmacokinetic studies after administration of icariin
    Liu, J
    Lou, YJ
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 36 (02) : 365 - 370
  • [6] Antidepressant-like effect of icariin and its possible mechanism in mice
    Pan, Y
    Kong, LD
    Xia, X
    Zhang, WY
    Xia, ZH
    Jiang, FX
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2005, 82 (04) : 686 - 694
  • [7] Regulation of Cbfa1 expression by total flavonoids of Herba epimedii
    Qian, GF
    Zhang, XZ
    Lu, LX
    Wu, XJ
    Li, SM
    Meng, J
    [J]. ENDOCRINE JOURNAL, 2006, 53 (01) : 87 - 94
  • [8] Bioanalytical Method Validation—A Revisit with a Decade of Progress
    Vinod P. Shah
    Kamal K. Midha
    John W. A. Findlay
    Howard M. Hill
    James D. Hulse
    Iain J. McGilveray
    Gordon McKay
    Krys J. Miller
    Rabindra N. Patnaik
    Mark L. Powell
    Alfred Tonelli
    C. T. Viswanathan
    Avraham Yacobi
    [J]. Pharmaceutical Research, 2000, 17 (12) : 1551 - 1557
  • [9] Stimulatory effect of daidzein in osteoblastic MC3T3-E1 cells
    Sugimoto, E
    Yamaguchi, M
    [J]. BIOCHEMICAL PHARMACOLOGY, 2000, 59 (05) : 471 - 475
  • [10] Estrogenic effects of two derivatives of icariin on human breast cancer MCF-7 cells
    Ye, HY
    Lou, YJ
    [J]. PHYTOMEDICINE, 2005, 12 (10) : 735 - 741